Axios reports:
Vivek Ramaswamy sold $33 million worth of shares in the biotech company he founded, as he fights to stay competitive in the GOP presidential primary race. Ramaswamy will use some of the proceeds to make a “significant investment” in his campaign, a spokesperson confirmed to Axios.
Ramaswamy sold three million shares in Roivant Sciences at $11.05 per share on Jan. 2, per an SEC filing. He previously sold $32 million of stock last February, timed to his presidential bid kickoff. The company’s stock price increased by nearly 29% between the two sales. He still holds over 50 million shares.
Read the full article.
SCOOP: Vivek Ramaswamy has sold $33 million worth of shares in Roivant Sciences, the biotech company he founded.
He says he’ll use some of the proceeds to make a “significant investment” in his 2024 campaign.https://t.co/a68G68Wfv6
— Axios (@axios) January 4, 2024